Match!
Adam D. Porath
Renown Health
WarfarinVitamin K antagonistDeep veinMedicineBlood pressure
3Publications
0Citations
What is this?
Publications 3
Newest
#1Adam D. Porath (Renown Health)
#2Sharon Clodfelter (Renown Health)
Last. Michael J. BlochH-Index: 10
view all 7 authors...
Abstract Purpose Renown Health (Reno, Nevada), a large, locally owned, not-for-profit integrated health care network, has developed an institution-wide policy to shift the treatment of deep vein thrombosis (DVT) from a short-acting anticoagulant and vitamin K antagonist to the direct oral anticoagulant rivaroxaban combined with pharmacy-directed follow-up at an outpatient anticoagulation clinic. We examined data on hospitalizations and costs pre–/post–policy change. Methods Data were obtained fr...
Source
Source
Source
1